Advertisement · 728 × 90

Posts by Transplant Infectious Disease

Preview
Kristen Panthagani, MD, PhD on Substack Prevention >>>> treatment. That's the beauty of vaccines. An animated, reimagined version of WSJ's measles visualization:

substack.com/@kmpanthagan...

11 months ago 0 0 0 0
Preview
Outcomes of lung transplantation from SARS-CoV-2 positive donors during the Omicron wave Early observations of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission via lung transplantation have led to frequent discard …

www.sciencedirect.com/science/arti...

Duke presents their experience transplanting SARS-CoV-2 NAT+ organ donors, in the era of good vaccines, good treatments & Omicron.

Great outcomes!
11 D+ vs 192 D- donors

@aussiedocwolfe.bsky.social @mady247.bsky.social
@ishlt.bsky.social @idsky.bsky.social

1 year ago 4 2 0 0
Preview
HOPE in every breath and heartbeat: Understanding transplant eligibility, access barriers, and clinical outcomes in thoracic transplantation in persons with HIV Persons with human immunodeficiency virus (PWH) are living longer, leading to increased end-organ disease from chronic illness. Organ transplantation …

Persons with HIV often can't find their way into transplant programs & face persistent institutional stigma. Thoracic transplant is especially restrictive.

HIV should not be a barrier. Fortunately, things are steadily improving:
#HOPEAct

www.sciencedirect.com/science/arti...

1 year ago 1 0 0 0
Preview
What is the Future of Treatments for COVID-19? In this raging flu season, where people with influenza-related illness outnumber those with COVID-19 for the first time since the pandemic hit in 2020, we might be fooled into thinking that we no long...

Remember #Covid? We STILL need better treatments.

@cidjournal.bsky.social just published an important clinical trial of ensitrelvir vs placebo.

Comments here, plus links to an excellent accompanying editorial by Drs Zim & @aussiedocwolfe.bsky.social.
#IDSky blogs.jwatch.org/hiv-id-obser...

1 year ago 34 3 1 0
Post image

#Measles
#Transplantation

If you want to learn more about how your transplant teams and patients should respond to measles - great webinar coming next week!
@kottonnelson.bsky.social @jobadd.bsky.social

1 year ago 5 1 0 0
TID Measles Guidance - TID Guidance August 2024 The Transplantation Society will provide the focus for global leadership in transplantation: development of the science and clinical practice, scientific communication, continuing education, guidance ...

#measles
Good chance to remind Transplant community about a great shared document created in 2024 by TTS / TID and the @ishlt.bsky.social

We didn't know it would become so timely!
tts.org/tid-guidelin...

1 year ago 5 2 1 0

? N.meningitidis? Seems too high a mortality rate for legionella, but perhaps. No discussion of VHF thankfully. Y.pestis? Cluster of H5 or imported MERs?? lots to evaluate, and not much in the media gives clues yet...

1 year ago 0 0 0 0
Preview
HIV/AIDS and COVID-19: Shared Lessons from Two Pandemics The HIV/AIDS and COVID-19 pandemics hold important lessons for preparing for, and responding to, future infectious disease outbreaks. Eight lessons common

As we prep for winter, & see the uptick of H5 cases, the fatalities in Congo etc, worth considering a great viewpoint from two experts - reflecting on their shared experiences with HIV & COVID.

Worth reading through, and pondering how transplant impacted ... #IDSky

academic.oup.com/cid/advance-...

1 year ago 7 0 0 0
Preview
WHO announces first prequalification of a tuberculosis diagnostic test The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. It is the first test for TB diagnosis and antibioti...

For our colleagues struggling with the daily realities of TB - especially in tricky patient populations like SOT - surely a helpful addition!! #IDSky

www.who.int/news/item/04...

1 year ago 4 0 0 0
Advertisement
Post image

... winter is coming...

1 year ago 0 0 0 0